Dotbio Pte News Today : Breaking News, Live Updates & Top Stories | Vimarsana

<b> Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved </b> <br/> <b>Expanding Portfolio with New Drug Innovations and Strategic R&amp;D Partnerships </b><b/> <br/> <br/> HONG KONG SAR - EQS Newswire - 27 March 2023 - A fully integrated biopharmaceutical company – <b>Uni-Bio Science Group Limited</b> ("Uni-Bio Science", together with its subsidiaries referred to as the "Group", stock code: 0690.HK), is pleased to announce its annual results for the year ended 31 December 2022 (the &...

DJ Uni-Bio Science Group Limited: 2022 Annual Results EQS Newswire / 27/03/2023 / 22:00 UTC+8 Record High Turnover of HKUSD440.3 Million and HKUSD38.5 Million Profit Achieved Expanding

EQS Newswire / 27/03/2023 / 22:00 UTC+8Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved Expanding Portfolio with New Drug Innovations and Strategic R&amp;D Partnerships &nbsp;[27 March 2023 – Hong Kong] A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (“Uni-Bio...

EQS-News / 22/03/2022 / 08:00 UTC+8&nbsp;Achieved Record-High Turnover and EGF Products Recorded Strong ReboundSuccessful Expansion Into Ophthalmology and Other Potential Therapeutic Areas&nbsp;[21 March 2022 - Hong Kong] A fully integrated biopharmaceutical company - Uni-Bio Science Group Limited ("Uni-Bio Science"...

SHANGHAI, China and SINGAPORE, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Shanghai Junshi Biociences Co., Ltd ("Junshi Biosciences", HKEX: 1877, SSE: 688180), a leading innovation-driven biopharmaceutical company